Serotype replacement in invasive pneumococcal disease: Where do we go from here?

被引：34

作者：

Hanage, W. P. ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England

来源：

JOURNAL OF INFECTIOUS DISEASES | 2007年 / 196卷 / 09期

基金：

英国惠康基金;

关键词：

ACUTE OTITIS-MEDIA; STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; CHILDREN; ERA; EFFICACY; ADULTS;

D O I：

10.1086/521630

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1282 / 1284

页数：3

共 13 条

[11] Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine [J].

Lexau, CA ;

Lynfield, R ;

Danila, R ;

Pilishvili, T ;

Facklam, R ;

Farley, MM ;

Harrison, LH ;

Schaffner, W ;

Reingold, A ;

Bennett, NM ;

Hadler, J ;

Cieslak, PR ;

Whitney, CG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (16) :2043-2051

[12] Glycoprotein conjugate vaccines [J].

Lindberg, AA .

VACCINE, 1999, 17 :S28-S36

[13] Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae [J].

Park, In Ho ;

Pritchard, David G. ;

Cartee, Rob ;

Brandao, Angela ;

Brandileone, Maria Cristina C. ;

Nahm, Moon H. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (04) :1225-1233

← 1 2 →